% 24.5% 23.1% 1.4% Expense to operating income ratio 45.5% 41.9% 47.4% 3.6% (1.9)% 43.5% 47.7% (4.2)% Return on average assets * 1.10% 1.06% 1.13% 0.04% (0.03)% 1.09% 1.09% - Return on average equity
. The growth resulted from the boost of promotions and marketing activities, enabling the Company to gain various and higher-potential clients and further strengthen its market position. The Company has
higher average market fuel price. As of 30 June 2018, The Company still has an obligation from fuel price hedging until September 2018 amounting to 1,080,000 barrels of jet fuel whereby jet fuel prices are
Integrated PET in Western markets have improved and we produce higher volume of PET in the premium market of Brazil. Core EBITDA margin increased to 13%. Core EBITDA per ton was $138, up 25% from 2017
) Financial costs (0.14) (0.34) (0.68) (111.47) Share of loss of joint venture (107.17) (261.90) (89.50) (14,672.13) Total expense (285.27) (697.14) (433.67) (71,093.44) Loss prior to income tax (272.97
= the market price per share of the Company’s ordinary shares A = Number of paid-up ordinary shares B = New ordinary shares reserved for the exercise of CCET-WC BX = the amount of proceeds received less
12,547 12,416 Gross profit margin (%) 22.84% 25.49% 26.48% Consolidated financial ratios 2018 2017 2016 Financial data and profitability ratios (continuous) Operating expense (include Research and
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
profit as baht, an addi While the Com 5 million bah any and subs tive Expense d expenses baht, which ous year. Th n baht which ajor selling a expenses inc s from busine of Financial alents vables t Cost ns